MedTrace Logo

Preoperative Dual Antiplatelet Therapy: Platelet Function and Influence of Cardiopulmonary Bypass

NCT02979158 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-03-29

No results posted yet for this study

Summary

Patients admitted for coronary artery bypass surgery taking antiplatelet medicine have an increased risk for bleeding.

Present study aims to compare the platelet function in two patient groups using different types of heart-lung machine methods.

It is assumed that one of the methods is superior verified by sensitive methods of testing platelet function.

Conditions

  • Cardiopulmonary Bypass
  • Platelet Disorder
  • Bleeding Disorder
  • Platelet Dysfunction Due to Drugs

Interventions

PROCEDURE

CPB Low Dose

Performing CPB with low dose heparin and coated equipment

PROCEDURE

CPB High Dose

Performing CPB with high dose heparin and uncoated equipment

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Umeå University

    lead OTHER

Principal Investigators

  • Ulf Näslund, MD PhD · Department of Publich Health and Clinical Medicin, Umeå University, Sweden

  • Magnus Hedström, MD · Heart Centre Umeå University Hospital Sweden

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-11-30
Primary Completion
2018-01-24
Completion
2018-01-24

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02979158 on ClinicalTrials.gov